| Non-intubated group n = 5 | IMV group n = 5 | P value |
---|---|---|---|
Male(n,%) | 4 (80%) | 2 (40%) | 0.003* |
Age (year) | 42 (30–49) | 17 (16–33) | 0.032* |
APACHEII | 6 (4–12) | 17 (11–21) | 0.028* |
PaO2/FiO2 | 230 (159–262) | 96 (51–158) | 0.032* |
Lactate | 0.9 (0.7–1.3) | 1.3 (1.2–1.7) | 0.056 |
Breathing rate (breaths/min) | 26 (25–31) | 27 (23–29) | 0.690 |
Tmax((°C)) | 40 (39.5–41.3) | 40 (39.7–40.9) | 0.841 |
Procalcitonin | 0.175 (0.14–0.195) | 1.05 (0.45–2.09) | 0.016* |
White blood cell count(109/L) | 4.5 (3.8–7.3) | 7.6 (5.5–8.7) | 0.151 |
Neutrophil proportion(%) | 73 (54–82) | 92 (83–94) | 0.016* |
AST (U/L) | 81 (33–102) | 100 (41–121) | 0.548 |
Albumin (g/L) | 29 (28–34) | 32 (26–39) | 1.0 |
Pre-albumin (g/L) | 0.08 (0.02–0.15) | 0.03 (0.03–0.04) | 0.571 |
Creatine (umol/L) | 55 (47–69) | 43 (35–76) | 1.0 |
C-reactive protein (CRP, mg/L) | 17 (6–48) | 93 (11–209) | 0.286 |
Erythrocyte sedimentation rate (ESR,mm/h) | 25 (5.5–28.5) | 12 (4–25) | 0.675 |
Length of onset to ICU admission (days) | 11 (9.5–14) | 14 (7.5–15) | 0.421 |
Length of ICU stay (days) | 4 (3–18.5) | 13 (17.5–23.5) | 0.056 |